返回 Agenda
Session 2: Perspectives in Regulatory Cooperation
Session Chair(s)
Marc Poitras, PHD, MBA
Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau, Health Canada, Canada
Karen Feltmate
President, Redstone Health Group, Inc., Canada
This session will provide a high-level context for the transformations in our regulations. From the Treasury Board of Canada Secretariat to the international arena, to the HTAs/Provinces/Territories at home. The industry perspective will also be presented to complete a fulsome review of regulatory cooperation in evolution.
Learning Objective : At the conclusion of this session, participants should be able to:- Describe the Canadian and international context for regulatory transformation
- Explain the intended benefits and potential pitfalls of proposed changes
- Discuss the current status of several new areas of cooperation
Speaker(s)
Jeannine Ritchot, MA
Executive Director of the Regulatory Policy and Cooperation Directorate, Treasury Board of Canada Secretariat, Canada
Canada’s Regulatory Modernization Agenda
Kristin Willemsen, MS
Vice President, Scientific & Regulatory Affairs, Food, Health & Consumer Products of Canada, Canada
Industry Perspectives on Regulatory Cooperation
David K. Lee
Chief Regulatory Officer for Health Product and Food Branch, Health Canada, Canada
Speaker
Keith McIntosh
Executive Director, Scientific & Regulatory Affairs, Innovative Medicines Canada, Canada
Speaker
Brian O'Rourke, PHARMD
President and Chief Executive Officer, Canadian Agency for Drugs and Technologies in Health, Canada
Transforming How We Manage Health Technologies